• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氧代金刚烷-1-基脲作为可溶型环氧水解酶抑制剂:在急性胰腺炎的小鼠模型中的评估。

2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: Evaluation in a Murine Model of Acute Pancreatitis.

机构信息

Laboratori de Quı́mica Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Quı́mica Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.

Pharmacology, Departament de Farmacologia, Toxicologia i Quı́mica Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.

出版信息

J Med Chem. 2020 Sep 10;63(17):9237-9257. doi: 10.1021/acs.jmedchem.0c00310. Epub 2020 Aug 25.

DOI:10.1021/acs.jmedchem.0c00310
PMID:32787085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7755424/
Abstract

pharmacological inhibition of soluble epoxide hydrolase (sEH) reduces inflammatory diseases, including acute pancreatitis (AP). Adamantyl ureas are very potent sEH inhibitors, but the lipophilicity and metabolism of the adamantane group compromise their overall usefulness. Herein, we report that the replacement of a methylene unit of the adamantane group by an oxygen atom increases the solubility, permeability, and stability of three series of urea-based sEH inhibitors. Most of these oxa-analogues are nanomolar inhibitors of both the human and murine sEH. Molecular dynamics simulations rationalize the molecular basis for their activity and suggest that the presence of the oxygen atom on the adamantane scaffold results in active site rearrangements to establish a weak hydrogen bond. The 2-oxaadamantane , which has a good solubility, microsomal stability, and selectivity for sEH, was selected for further and studies in models of cerulein-induced AP. Both in prophylactic and treatment studies, diminished the overexpression of inflammatory and endoplasmic reticulum stress markers induced by cerulein and reduced the pancreatic damage.

摘要

药物抑制可水解型环氧合酶(sEH)可减少炎症性疾病,包括急性胰腺炎(AP)。金刚烷脲类化合物是非常有效的 sEH 抑制剂,但金刚烷基团的亲脂性和代谢会影响其整体效果。本研究报告称,用氧原子取代金刚烷基团中的亚甲基单元会增加基于脲的 sEH 抑制剂三个系列的溶解度、通透性和稳定性。这些氧杂类似物中的大多数对人和鼠 sEH 均为纳摩尔级抑制剂。分子动力学模拟为其活性提供了合理的解释,并表明在金刚烷支架上存在氧原子会导致活性位点发生重排,从而建立弱氢键。2-氧杂金刚烷具有良好的水溶性、微粒体稳定性和 sEH 选择性,被选中用于进一步研究和治疗亮抑蛋白酶肽诱导的 AP 模型。在预防性和治疗性研究中,均能减轻亮抑蛋白酶肽诱导的炎症和内质网应激标志物的过度表达,并减轻胰腺损伤。

相似文献

1
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: Evaluation in a Murine Model of Acute Pancreatitis.2-氧代金刚烷-1-基脲作为可溶型环氧水解酶抑制剂:在急性胰腺炎的小鼠模型中的评估。
J Med Chem. 2020 Sep 10;63(17):9237-9257. doi: 10.1021/acs.jmedchem.0c00310. Epub 2020 Aug 25.
2
From the Design to the Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis.从苯并高金刚烷衍生的可溶性环氧化物水解酶抑制剂的设计到治疗急性胰腺炎的评估
J Med Chem. 2021 May 13;64(9):5429-5446. doi: 10.1021/acs.jmedchem.0c01601. Epub 2021 May 4.
3
1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.以异恶唑为可溶环氧化物水解酶抑制剂的1,3-二取代和1,3,3-三取代金刚烷基脲
Bioorg Med Chem Lett. 2015 Dec 1;25(23):5514-9. doi: 10.1016/j.bmcl.2015.10.066. Epub 2015 Oct 23.
4
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.探究可溶性环氧化物水解酶抑制剂疏水区部分的大小。
Bioorg Med Chem. 2019 Oct 15;27(20):115078. doi: 10.1016/j.bmc.2019.115078. Epub 2019 Aug 26.
5
Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.咪唑烷-2,4,5-二酮和嘧啶-2,4,6-三酮——具有增强水溶性的可溶性环氧化物水解酶抑制剂的新型主要药效基团。
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126908. doi: 10.1016/j.bmcl.2019.126908. Epub 2019 Dec 18.
6
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.发现美金刚脲衍生物作为有效的可溶性环氧化物水解酶抑制剂可对抗脂多糖诱导的败血症。
Eur J Med Chem. 2021 Nov 5;223:113678. doi: 10.1016/j.ejmech.2021.113678. Epub 2021 Jun 29.
7
Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).新型 1-芳基-3-(1-酰基哌啶-4-基)脲作为人可溶性环氧化物水解酶抑制剂 (sEHIs) 的药效团建模和基于原子的 3D-QSAR 研究。
Med Chem. 2011 Nov;7(6):581-92. doi: 10.2174/157340611797928479.
8
Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.金刚烷修饰对可溶性环氧化物水解酶抑制活性、物理性质和代谢稳定性的影响。
Bioorg Chem. 2018 Feb;76:510-527. doi: 10.1016/j.bioorg.2017.12.024. Epub 2017 Dec 30.
9
Adamantyl thioureas as soluble epoxide hydrolase inhibitors.金刚烷基硫脲作为可溶性环氧化物水解酶抑制剂
Bioorg Med Chem Lett. 2018 Jul 15;28(13):2302-2313. doi: 10.1016/j.bmcl.2018.05.024. Epub 2018 May 23.
10
Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.用双环亲脂性基团对金刚烷进行生物电子等排取代可提高人可溶性环氧化物水解酶抑制剂的水溶性。
Bioorg Med Chem Lett. 2020 Sep 15;30(18):127430. doi: 10.1016/j.bmcl.2020.127430. Epub 2020 Jul 24.

引用本文的文献

1
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis.设计、合成及一种强力可溶性环氧化物水解酶抑制剂的药理学特征,用于治疗急性胰腺炎。
J Med Chem. 2023 Jul 13;66(13):9201-9222. doi: 10.1021/acs.jmedchem.3c00831. Epub 2023 Jun 19.
2
Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits.可溶性环氧化物水解酶抑制剂的筛选和生物学评价:评估疏水性在基于药效团的新型命中物搜索中的作用。
J Chem Inf Model. 2023 May 22;63(10):3209-3225. doi: 10.1021/acs.jcim.3c00301. Epub 2023 May 4.
3

本文引用的文献

1
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease.抑制可溶性环氧化物水解酶作为阿尔茨海默病的一种新疗法。
Neurotherapeutics. 2020 Oct;17(4):1825-1835. doi: 10.1007/s13311-020-00854-1.
2
Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog.里特反应介导的新型金刚烷胺类似物2-氧杂金刚烷-5-胺的合成。
Tetrahedron Lett. 2015 Mar 4;56(10):1272-1275. doi: 10.1016/j.tetlet.2015.01.160. Epub 2015 Jan 31.
3
LogP prediction performance with the SMD solvation model and the M06 density functional family for SAMPL6 blind prediction challenge molecules.
Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases.
结构导向的强效可溶性环氧化物水解酶抑制剂的发现用于治疗炎症性疾病。
J Med Chem. 2023 Feb 23;66(4):2979-3009. doi: 10.1021/acs.jmedchem.2c01996. Epub 2023 Jan 23.
4
Chemical Chaperones to Inhibit Endoplasmic Reticulum Stress: Implications in Diseases.化学伴侣抑制内质网应激:在疾病中的意义。
Drug Des Devel Ther. 2022 Dec 23;16:4385-4397. doi: 10.2147/DDDT.S393816. eCollection 2022.
5
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.发现美金刚脲衍生物作为有效的可溶性环氧化物水解酶抑制剂可对抗脂多糖诱导的败血症。
Eur J Med Chem. 2021 Nov 5;223:113678. doi: 10.1016/j.ejmech.2021.113678. Epub 2021 Jun 29.
6
From the Design to the Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis.从苯并高金刚烷衍生的可溶性环氧化物水解酶抑制剂的设计到治疗急性胰腺炎的评估
J Med Chem. 2021 May 13;64(9):5429-5446. doi: 10.1021/acs.jmedchem.0c01601. Epub 2021 May 4.
7
Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.小分子可溶环氧化物水解酶抑制剂在炎症和癌症的多靶点和联合治疗中的应用。
Molecules. 2020 Nov 24;25(23):5488. doi: 10.3390/molecules25235488.
SMD 溶剂化模型和 M06 密度泛函家族对 SAMPL6 盲测挑战分子的 LogP 预测性能。
J Comput Aided Mol Des. 2020 May;34(5):511-522. doi: 10.1007/s10822-020-00278-1. Epub 2020 Jan 14.
4
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.探究可溶性环氧化物水解酶抑制剂疏水区部分的大小。
Bioorg Med Chem. 2019 Oct 15;27(20):115078. doi: 10.1016/j.bmc.2019.115078. Epub 2019 Aug 26.
5
Using AMBER18 for Relative Free Energy Calculations.使用 AMBER18 进行相对自由能计算。
J Chem Inf Model. 2019 Jul 22;59(7):3128-3135. doi: 10.1021/acs.jcim.9b00105. Epub 2019 Jun 20.
6
The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.花生四烯酸单加氧酶:从生化好奇到生理/病理生理意义。
J Lipid Res. 2018 Nov;59(11):2047-2062. doi: 10.1194/jlr.R087882. Epub 2018 Aug 28.
7
Epoxide Hydrolase Conformational Heterogeneity for the Resolution of Bulky Pharmacologically Relevant Epoxide Substrates.环氧化物水解酶构象异质性在拆分大体积的具有药理学相关性的环氧化物底物中的应用。
Chemistry. 2018 Aug 22;24(47):12254-12258. doi: 10.1002/chem.201801068. Epub 2018 May 25.
8
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.可溶性环氧化物水解酶作为治疗疼痛、炎症和神经退行性疾病的靶点。
Pharmacol Ther. 2017 Dec;180:62-76. doi: 10.1016/j.pharmthera.2017.06.006. Epub 2017 Jun 19.
9
The Changing Epidemiology of Acute Pancreatitis Hospitalizations: A Decade of Trends and the Impact of Chronic Pancreatitis.急性胰腺炎住院治疗的流行病学变化:十年趋势及慢性胰腺炎的影响
Pancreas. 2017 Apr;46(4):482-488. doi: 10.1097/MPA.0000000000000783.
10
Acute Pancreatitis.急性胰腺炎
N Engl J Med. 2016 Nov 17;375(20):1972-1981. doi: 10.1056/NEJMra1505202.